Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$59,887,500
-$34,905,000 QoQ
Shares Held
1,875,000
-24.2% QoQ
Ownership
3.14%
of shares outstanding
% of Portfolio
3.59%
of 13F equity value
Holder Rank
#10
of 169 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Commodore Capital LP holds $1,375,688,495 across 28 Biotechnology names. TYRA ranks #9 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLAY |
Relay Therapeutics, Inc.
|
12,000,000 | $224,520,000 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
3,275,000 | $166,206,250 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,050,000 | $118,035,000 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
2,000,000 | $94,080,000 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
846,786 | $75,177,661 | |
| 6 | ANRO |
Alto Neuroscience, Inc.
|
2,723,196 | $71,865,142 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,250,000 | $70,335,000 | |
| 8 | EYPT |
EyePoint, Inc.
|
4,600,000 | $65,780,000 |
All Filings in TYRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,887,500 | 1,875,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $94,792,500 | 2,475,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,728,750 | 3,375,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $47,216,250 | 3,375,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,667,000 | 3,100,000 | Shares | Sole | 2025-08-14 | |
| 2025-05-07 | $25,107,500 | 2,750,000 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $8,835,000 | 950,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||